These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2497402)

  • 21. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke.
    von Kummer R; Hacke W
    Stroke; 1992 May; 23(5):646-52. PubMed ID: 1579960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrathrombus administration of tissue plasminogen activator in acute cerebrovascular occlusion.
    Frey JL; Greene KA; Khayata MH; Dean BL; Hodak JA; Spetzler RF
    Angiology; 1995 Aug; 46(8):649-56. PubMed ID: 7639410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant tissue plasminogen activator in two patients with basilar artery occlusion.
    Herderscheê D; Limburg M; Hijdra A; Koster PA
    J Neurol Neurosurg Psychiatry; 1991 Jan; 54(1):71-3. PubMed ID: 1901349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The simple indicator for revascularization of acute middle cerebral artery occlusion using angiogram and ultra-early embolectomy.
    Kakinuma K; Ezuka I; Takai N; Yamamoto K; Sasaki O
    Surg Neurol; 1999 Mar; 51(3):332-41. PubMed ID: 10086500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
    J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnostic image (162) A woman with temporary hemiplegia. Temporary embolic occlusion of the left middle cerebral artery by a thrombus].
    Groeneveld GJ; van der Schaaf IC
    Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2123. PubMed ID: 14619203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome.
    Brandt T; von Kummer R; Müller-Küppers M; Hacke W
    Stroke; 1996 May; 27(5):875-81. PubMed ID: 8623107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke.
    Thomas GR; Thibodeaux H; Bennett WF; Refino CJ; Badillo JM; Errett CJ; Zivin JA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):67-73. PubMed ID: 8423552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The safety and angiographic efficacy of tissue plasminogen activator in a cerebral embolization model.
    Phillips DA; Fisher M; Smith TW; Davis MA
    Ann Neurol; 1988 Apr; 23(4):391-4. PubMed ID: 3132892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triphasic perfusion computed tomography in acute middle cerebral artery stroke: a correlation with angiographic findings.
    Lee KH; Cho SJ; Byun HS; Na DG; Choi NC; Lee SJ; Jin IS; Lee TG; Chung CS
    Arch Neurol; 2000 Jul; 57(7):990-9. PubMed ID: 10891981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
    Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients.
    Lee KY; Han SW; Kim SH; Nam HS; Ahn SW; Kim DJ; Seo SH; Kim DI; Heo JH
    Stroke; 2007 Jan; 38(1):192-3. PubMed ID: 17110611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed treatment with a t-PA analogue and streptokinase in a rabbit embolic stroke model.
    Phillips DA; Fisher M; Davis MA; Smith TW; Pang RH
    Stroke; 1990 Apr; 21(4):602-5. PubMed ID: 2109376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator.
    Linfante I; Llinas RH; Selim M; Chaves C; Kumar S; Parker RA; Caplan LR; Schlaug G
    Stroke; 2002 Aug; 33(8):2066-71. PubMed ID: 12154264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion.
    Molina CA; Alvarez-Sabín J; Montaner J; Abilleira S; Arenillas JF; Coscojuela P; Romero F; Codina A
    Stroke; 2002 Jun; 33(6):1551-6. PubMed ID: 12052990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of cardiogenic cerebral embolism with successful recanalization: apparent diffusion coefficient analysis for prediction of reversible cerebral ischemia].
    Matsuda W; Sugimoto K; Sato N; Watanabe T; Hattori A; Matsumura A; Nose T
    No To Shinkei; 2000 Mar; 52(3):243-8. PubMed ID: 10769845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can catheter-directed thrombolysis be applied to acute lower extremity artery embolism after recent cerebral embolism from atrial fibrillation?
    Si TG; Guo Z; Hao XS
    Clin Radiol; 2008 Oct; 63(10):1136-41. PubMed ID: 18774361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dynamic concept of middle cerebral artery occlusion and cerebral infarction in the acute state based on interpreting severe hyperemia as a sign of embolic migration.
    Olsen TS; Lassen NA
    Stroke; 1984; 15(3):458-68. PubMed ID: 6729875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombolytic efficacy of a modified tissue-type plasminogen activator, SUN9216, in the rat middle cerebral artery thrombosis model.
    Umemura K; Toshima Y; Nakashima M
    Eur J Pharmacol; 1994 Sep; 262(1-2):27-31. PubMed ID: 7813575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.